Consistent with the proteomic results, the level of platelet OPTN was significantly increased in T2DM‐MCI patients (n = 34) compared with the T2DM‐nMCI patients (n = 30) (Figure 5k‐l). The gene discussed is OPTN; the disease is type 2 diabetes mellitus.